A NovoCare® Recognized Care Provider, Weight Watchers’ new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication alone NEW YORK, Jan. 05, ... Markets Insider: Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect WW International, Inc.

Context Explanation

(NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, announced that it is now offering access to Eli Lilly and Company’s newly FDA-approved ... Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect Nasdaq: Weight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy® Pill Advancing a New Standard for Long-Term Weight Health Weight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy® Pill Advancing a New Standard for Long-Term Weight Health Investing.com India: Weight Watchers stock jumps on new Eli Lilly GLP-1 offering Investing.com -- Weight Watchers (NASDAQ:WW) shares rose 17% Thursday after the company announced it will offer Eli Lilly and Company’s newly FDA-approved oral GLP-1 medication Foundayo (orforglipron) ...